你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
1116NS-3d
1116NS-3d
规格:
货期:
编号:TS213073
品牌:Testobio
产品名称: 1116NS-3d
商品货号: TS213073
Organism: Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)
Cell Type: hybridoma: B lymphocyte
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: Adenocarcinoma
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Derivation:
Spleen cells were fused with P3X63Ag8 myeloma cells.
Genes Expressed:
immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA)
Cellular Products:
immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA)
Comments:
Animals were immunized with a human colonic adenocarcinoma (SW1116, ATCC CCL-233).
Spleen cells were fused with P3X63Ag8 myeloma cells.
Complete Growth Medium: The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
Subculturing:
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Isotype: IgM
Name of Depositor: Wistar Institute
Deposited As: mouse (B cell); mouse (myeloma)
U.S. Patent Number:
References:

Koprowski H, et al. Monoclonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen. US Patent 4,349,528 dated Sep 14 1982

首页 > 产品中心 > 微生物培养 > 菌株 > null > 1116NS-3d

1116NS-3d

  • 货号: TS213073
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: 1116NS-3d
商品货号: TS213073
Organism: Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)
Cell Type: hybridoma: B lymphocyte
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: Adenocarcinoma
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Derivation:
Spleen cells were fused with P3X63Ag8 myeloma cells.
Genes Expressed:
immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA)
Cellular Products:
immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA)
Comments:
Animals were immunized with a human colonic adenocarcinoma (SW1116, ATCC CCL-233).
Spleen cells were fused with P3X63Ag8 myeloma cells.
Complete Growth Medium: The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
Subculturing:
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Isotype: IgM
Name of Depositor: Wistar Institute
Deposited As: mouse (B cell); mouse (myeloma)
U.S. Patent Number:
References:

Koprowski H, et al. Monoclonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen. US Patent 4,349,528 dated Sep 14 1982

合作单位: